Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-04-04
2010-11-02
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S091100, C435S325000, C435S375000
Reexamination Certificate
active
07825098
ABSTRACT:
Described herein are methods for identifying and using inhibitors of Necdin function to promote brown adipose tissue (BAT) differentiation, thereby treating obesity.
REFERENCES:
patent: WO 03/026576 (2003-04-01), None
Lu et al. (2005) “Delivering siRNA in vivo for functional genomics and novel therapies” in RNA Interference Technology, Appasaini, ed. (Cambridge University Press: Cambridge, UK) p. 303-307.
Samarsky et al. (2005) “RNAi in drug development: Practical considerations” in RNA Interference Technology Appasaini, ed. (Cambridge University Press: Cambridge, UK) p. 384-395.
Teng et al. (Nature Cell Biology, 2005 vol. 7:601-611).
Boeuf et al., “Differential gene expression in white and brown preadipocytes,” Physiol. Genomics 7:15-26 (2001).
Kahn C. Ronald
Tseng Yu-Hua
Fish & Richardson P.C.
Gibbs Terra Cotta
Joslin Diabetes Center, Inc.
McGarry Sean
LandOfFree
Methods and compositions for modulating Necdin function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for modulating Necdin function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for modulating Necdin function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4244125